Orteronel

• Target:

  Cytochromes P450

• Related Pathways:

  Metabolism

• Bioactivity:

  Orteronel ((S) -Orteronel) (TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.

• Smiles:

  CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12

• Molecular Formula:

  C18H17N3O2

• Molecular Weight:

  307.35

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  566939-85-3